Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 1 - General processes for the preparation of peptides
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
05/1991
05/15/1991EP0427142A1 Antibiotic A/16686 recovery process
05/15/1991EP0426787A1 POLYPEPTIDE RESULTING FROM THE FUSION BETWEEN A MALTOSE-RELATED COMPOUND (MalE) AND A CD4 FRAGMENT FOR NEUTRALIZING THE AIDS VIRUS
05/15/1991EP0426778A1 Apparatus and method for the sequential performance of chemical processes
05/15/1991EP0426762A1 Process for producing dipeptides from non-proteinogenic amino acids with terminal carbon atoms.
05/15/1991EP0357730A4 Blocking, isolating and purifying calcium channels
05/15/1991CN1051389A Novel antibodies reactive with human carcinomas
05/14/1991WO1991007494A1 Chimeric mouse human antibodies with specificity to hiv antigens
05/14/1991WO1991007434A1 Control of milk secretion
05/14/1991WO1991007418A1 Chimeric mouse-human a10 antibody with specificity to a human tumor cell antigen
05/14/1991US5015350 Flow-rate-controlled surface-charge coating for capillary electrophoresis
05/14/1991CA2068515A1 Control of milk secretion
05/14/1991CA2044627A1 Chimeric mouse human antibodies with specificity to hiv antigens
05/14/1991CA2044609A1 Chimeric mouse human antibodies with specificity to hiv antigens
05/14/1991CA2044590A1 Chimeric mouse-human a10 antibody with specificity to a human tumor cell antigen
05/14/1991CA2029766A1 Polypeptide compound and a process for preparation thereof
05/14/1991CA1284250C Viscoelastic collagen solution for ophthalmic use and method of preparation
05/14/1991CA1284249C Process for purifying proinsulin-like materials
05/10/1991WO1991007438A1 A method for isolating factor viii
05/09/1991WO1991007433A1 Peptide and process for preparing cyclic peptide
05/09/1991CA2045495A1 Peptides and processes for producing cyclic peptides
05/08/1991WO1991006305A1 Oligomeric immunoglobulins
05/08/1991EP0426488A1 Production of modified superoxide dismutase
05/08/1991EP0426458A2 Human monocyte growth factor
05/08/1991EP0425892A2 Process for enhancing the bioavailability of drugs with peptide bonds
05/08/1991DE3936777A1 Quervernetzte tumor-nekrose-faktoren Cross-linked tumor necrosis factors
05/08/1991DE3935738A1 Arzneimittel, enthaltend das humane parathormon-fragment (1-37) als aktiven wirkstoff A drug containing the human parathyroid hormone-fragment (1-37) as the active drug
05/08/1991CN1051182A Polypeptides useful as blockers of calcium channels
05/08/1991CA2045150A1 Oligomeric immunoglobulins
05/08/1991CA2029457A1 Modified forms of human erythropoietin and dna sequences encoding genes which can express them
05/07/1991WO1991006563A1 Reduced irreversible bombesin antagonists
05/07/1991US5013723 New thymopentin retro-inverso analogs and fragments thereof, a process of preparation of the new compounds and the intermediates obtained therein
05/07/1991CA2045494A1 Reduced irreversible bombesin antagonists
05/07/1991CA2029289A1 Insulin derivatives, process for their preparation, their use and a pharmaceutical preparation containing them
05/07/1991CA1284000C Process for recovering glucagon from pancreas glands
05/07/1991CA1283856C Purification of immunoglobulin g
05/03/1991CA2029216A1 Process of producing modified superoxide dismutase
05/02/1991WO1991005871A1 Bispecific heteroantibodies with dual effector functions
05/02/1991WO1991005867A1 Erythropoietin isoforms
05/02/1991WO1991005802A1 Osteogenic devices
05/02/1991WO1991005795A1 Stem cell factor
05/02/1991WO1991005564A1 Synthesis and use of amino acid fluorides as peptide coupling reagents
05/02/1991EP0425212A2 Cyclic anti-aggregatory peptides
05/02/1991EP0425096A1 Polypeptides useful as blockers of calcium channels
05/02/1991EP0424819A1 Reversible modification of biological compounds for detection, separation and purification thereof
05/02/1991EP0424670A1 ZNS-active hexapeptides with antiamnestic activity
05/02/1991EP0424519A1 Antigenes of the envelope transmembrane glycoprotein of a human retrovirus of the hiv-2 type, and antigens presenting with them an immunological relationship.
05/02/1991EP0424498A1 Process for preparation of activated protein c.
05/02/1991EP0214232B1 Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor
05/02/1991EP0205564B1 Method for the production of erythropoietin
05/02/1991DE3935572A1 Verfahren zur peptidsynthese und traeger dafuer A method for peptide synthesis and carrier therefor
05/02/1991CA2042577A1 Osteogenic devices
05/01/1991WO1991006356A1 Method to identify analyte-binding ligands
05/01/1991CA2072637A1 Method to identify analyte-binding ligands
05/01/1991CA2027317A1 Vaccine composition with non-immunosuppressive t-cell epitope component
04/1991
04/30/1991US5011825 Treatment of hypertension, diabetes, edema
04/29/1991CA2028665A1 Bioavailability of pharmaceutical active compounds with peptide linkages
04/28/1991WO1991006564A1 hPTH (1-37) FRAGMENT, ITS PRODUCTION, DRUG CONTAINING IT AND ITS USE
04/25/1991WO1991006647A1 Gastrin releasing peptide receptor
04/25/1991WO1991006646A1 Solubilization and purification of the gastrin releasing peptide receptor
04/25/1991CA2069965A1 Solubilization and purification of the gastrin releasing peptide receptor
04/25/1991CA2067766A1 Gastrin releasing peptide receptor
04/24/1991EP0424351A2 Modified heparin cofactor II
04/24/1991EP0423980A1 Stem cell factor
04/24/1991EP0423938A1 Ligand-containing medium for chromatographic separation, process for preparing the medium, and use of the medium for isolating synthetic or natural molecules from a fluid mixture
04/24/1991EP0423207A1 A migration stimulating factor
04/23/1991US5010176 Malonate linker
04/23/1991US5010175 Reacting activated amino acids with an acceptor amino acid or peptide in relative concentrations based on relative coupling constants so that the resulting mixture of peptides contains each peptide in predictable amounts
04/23/1991US5010097 Collagenase inhibitors, antiarthritic agents
04/23/1991US5010057 Renin-inhibiting peptides having an aminomethyl side chain
04/23/1991US5009861 Crystallization apparatus
04/23/1991CA1283499C Peptides
04/21/1991CA2028082A1 Modified heparin cofactor ii
04/18/1991WO1991005047A1 THE HUMAN C3b/C4b RECEPTOR (CR1)
04/18/1991WO1991004985A1 Dehydrodidemnin b
04/18/1991WO1991004743A1 Stabilized aqueous formulations of small peptides
04/18/1991DE3933850A1 Zytolyse-inhibitor (zli), eine diese blutplasmaprotein kodierende dna-sequenz, sowie ein plasmid, ein wirtsorganismus und ein verfahren zur gewinnung dieses proteins Cytolysis inhibitor (ZLI), these a blood plasma protein encoding DNA sequence, and a plasmid, a host organism and a method for obtaining this protein
04/17/1991EP0422566A1 A process for the preparation of 3-(L-pyroglutamyl)-L-thiazolidine-4-carboxylic acid derivatives
04/17/1991EP0422339A1 Tumor necrosis factor (TNF) inhibitor and method for obtaining the same
04/17/1991EP0422124A1 Thermal release of recombinant protein into culture media
04/17/1991EP0344177A4 Porous wafer for segmented synthesis of biopolymers
04/17/1991EP0236307B1 Antihypertensive agents, pharmaceutical compositions containing them and processes for the preparation of the agents and compositions
04/17/1991CN1050721A Radiolabeled anticoagulant peptides
04/17/1991CN1050720A Anticoagulant peptides
04/17/1991CA2267658A1 Use of stem cell factor polypeptide to stimulate growth of epithelial cells
04/17/1991CA2267643A1 Use of stem cell factor polypeptide as an anti-hematopoietic disorder agent
04/17/1991CA2267626A1 Use of stem cell factor polypeptide to stimulate growth of stromal cells
04/16/1991US5008400 Bicyclic aminoacids as intermediates
04/16/1991US5008377 Contacting with nuclear sulfonic acid cation ion exchange resin
04/16/1991US5008372 Deblocking amino terminal N-acetyl serine and N-acetyl threonine residues in peptides and proteins to allow sequencing
04/16/1991US5008371 Biologically active polypeptide and use thereof
04/16/1991US5008273 Amino acid derivatives and their pharmaceutical use
04/16/1991US5008246 Novel peptides suppressing the function of the immune system, pharmaceutical compositions containing them and process for preparing same
04/16/1991US5008220 Biological support
04/16/1991CA1283248C Substrates for hydrolases, a method for their preparation and their use
04/16/1991CA1283072C Process for the isolation and separation of lysozyme and avidin from eggwhite
04/16/1991CA1283045C Therapeutic and diagnostic methods using soluble t cell surface molecules
04/14/1991WO1991005796A1 Carboxyalkyl dipeptide inhibitors of endopeptidases
04/14/1991CA2069312A1 Carboxyalkyl dipeptide inhibitors of endopeptidases
04/12/1991WO1991006008A1 Method for purifying chelator conjugated compounds
04/12/1991CA2069303A1 Method for purifying chelator conjugated compounds
1 ... 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 ... 518